Search results
Cantor Fitzgerald Brokers Boost Earnings Estimates for Merck & Co., Inc. (NYSE:MRK)
ETF DAILY NEWS· 2 days agoMerck & Co., Inc. (NYSE:MRK – Free Report) – Equities research analysts at Cantor Fitzgerald increased their FY2024 earnings per share (EPS) estimates for ...
Merck's KEYTRUDA shows survival benefit in gastric cancer trial By Investing.com
Investing.com· 17 hours agoMerck & Co., Inc., a leading pharmaceutical company, announced positive results from the Phase 3...
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoMerck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript April 25, 2024 Merck & Co., Inc. beats...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 4 hours agoThis analysed R&D investments were in the form of strategic acquisitions to expand a company’s prowess in a particular area or by in-licensing drug...
Merck & Co., Inc. (NYSE:MRK) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Simply Wall St. via Yahoo Finance· 5 days agoMerck & Co., Inc. (NYSE:MRK) just released its quarterly report and things are looking bullish. The...
Merck reports promising V116 vaccine trial results By Investing.com
Investing.com· 3 days agoMerck & Co. (NYSE: MRK) has presented new data from its Phase 3 STRIDE-10 trial of V116, an...
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
WSAU Wausau· 7 days agoBy Patrick Wingrove (Reuters) - Merck & Co on Thursday raised its annual profit and revenue forecast...
15 Best Places to Retire in Florida That You’ve Never Heard Of
Insider Monkey via Yahoo Finance· 12 hours agoThis article takes a look at the 15 best places to retire in Florida that you’ve never heard of. If...
Merck: Q1 Earnings Snapshot
Associated Press Finance via Yahoo Finance· 7 days agoRAHWAY, N.J. (AP) — RAHWAY, N.J. (AP) — Merck & Co. (MRK) on Thursday reported first-quarter earnings of $4.76 billion. On a per-share basis, the Rahway ...
UPDATE 3-Merck raises 2024 profit forecast on surging sales of cancer drug Keytruda
Reuters via Yahoo Finance· 7 days agoMerck & Co on Thursday raised its annual profit and revenue forecasts on the back of double-digit growth for its blockbuster cancer drug Keytruda, the world's ...
